Mark Novas

2.3k citations
24 papers · 1.6k · 1 hit paper · h-index 8

Impact in

Papers in

Mark Novas

22 papers receiving 1.5k citations

Mark Novas's Hit Papers

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis 2012 · 1.1k citations
1.1k0+4+9Years since publication2505007501000

Peers

Mark Novas
Comparison fields: 5 of 90
  • Pathology and Forensic Medicine 1.1k
  • Neurology 234
  • Neurology 105
  • Biological Psychiatry 30
  • Rheumatology 177
Replace Kartik Raghupathi with:
Kartik Raghupathi United States
Małgorzata Leyk United States
Alexander Korn Germany
Roberto Bomprezzi United States
Leifur Thorsteinsson Iceland
Michael J. Primiano United States
Renato Vanacore Italy
Agnieszka Bojarska−Junak Poland
Kazuhide Ochi Japan
Takashi Ninomiya Japan
Mark Novas relative to Kartik Raghupathi United States Kartik Raghupathi's profile →
Citations per field
00.5×1.5×
Kartik Raghupathi · 1×
Citations per year

Countries citing papers authored by Mark Novas

Since Specialization
Citations

This map shows the geographic impact of Mark Novas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Novas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Novas more than expected).

Fields of papers citing papers by Mark Novas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Novas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Novas. The network helps show where Mark Novas may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Novas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Novas Line = papers co-authored together Mark Novas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Hit paper breakdown →
20121084
2 2016113
3 201391
4 201373
5 201572
6 201550
7 201349
8 20157
9 20137
10 20126
11 20146
12 20125
13 20154
14 20154
15 20133
16 20133
17
Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study
20122
18
Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
20122
19 20142
20
Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study
20131

About Mark Novas

Mark Novas is a scholar working on Pathology and Forensic Medicine, Ecology, Evolution, Behavior and Systematics, Oncology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (11 papers), Mycobacterium research and diagnosis (3 papers), Fungal Plant Pathogen Control (3 papers), Polyomavirus and related diseases (2 papers), Pregnancy and Medication Impact (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Cancer Risks and Factors (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Neurology (234 citations), Neurology (105 citations), Biological Psychiatry (30 citations) and Rheumatology (177 citations). Mark Novas has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include Robert J. Fox, J. Theodore Phillips, Eva Havrdová, Katherine Dawson, Vissia Viglietta, Mariko Kita, Michael Hutchinson, Marianne T. Sweetser, David H. Miller and Minhua Yang. Their work appears in journals such as Neurology, Journal of the Neurological Sciences, International Journal of MS Care, Clinical Therapeutics and Neurology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact